English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17933/22952 (78%)
Visitors : 7351485      Online Users : 190
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/23554


    Title: Contribution of Interleukin-10 Genotype to Triple Negative Breast Cancer Risk
    Authors: Chen, KY;Chien, WC;Liao, JM;Tsai, CW;Chang, WS;Su, CH;Hsu, SW;Wang, HC;Bau, DT
    Keywords: Breast cancer;genotype;interleukin-10;polymorphism;Taiwan
    Date: 2021
    Issue Date: 2022-08-05T09:39:09Z (UTC)
    Publisher: INT INST ANTICANCER RESEARCH
    ISSN: 0250-7005
    Abstract: Background/Aim: Triple negative breast cancer (TNBC) is characterized by increased recurrence and poor survival. Mounting evidence suggests that interleukin-10 (IL-10) plays a role in carcinogenesis, however, little is known about the contribution of IL-10 to TNBC. The study evaluated the contribution of IL-10 promoter A-1082G (rs1800896), T-819C (rs3021097), A-592C (rs1800872) genotypes to the risk of TNBC. Materials and Methods: IL-10 genotypes were examined among 1,232 breast cancer patients and 1,232 controls and evaluated. Results: The percentages of AG and GG for IL-10 A 1082G genotypes were higher in the breast cancer patient group than in the control group. The GG genotype carriers were of higher risk for breast cancer [odds ratio (OR)=2.02, 95% confidence interval (CI)=1.28-3.21, p=0.0021]. Interestingly, G allele carriers were of higher risk of TNBC (OR=1.25, 95%CI=1.07-1.46, p=0.0050). Conclusion: The G allele of IL 10 A-1082G genotype may serve as a predictor for TNBC risk. The finding should be validated in other populations.
    URI: http://dx.doi.org/10.21873/anticanres.15020
    https://www.webofscience.com/wos/woscc/full-record/WOS:000648665800012
    https://ir.csmu.edu.tw:8080/handle/310902500/23554
    Relation: ANTICANCER RESEARCH ,2021,v41,issue 5, P2451-2457
    Appears in Collections:[中山醫學大學研究成果] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML194View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback